Cite
APA Citation
Maarup, S., Skadborg, S., Borch, A., Draghi, A., Hasselbalch, B., Østrup, O., Scheie, D., Skjoeth-Rasmussen, J., Law, I., Svane, I. M., Poulsen, H., Hadrup, S., & Lassen, U. (2021). cTIM-22. NIVOLUMAB AND BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA; T-CELL REACTIVITY AGAINST AUTOLOGOUS TUMOR CELLS. Neuro-oncology, 23, vi54–vi55. http://access.bl.uk/ark:/81055/vdc_100146089652.0x00001b